← All APHA Flashcard Decks

Mixed Deck — All APHA Topics Flashcards

100 cards from real APHA practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 20 Mixed Deck — All APHA Topics flashcards as text
  1. Which of the following is a key performance indicator for evaluating risk management & mitigation effectiveness?

    Answer: Prioritizing based on risk assessment and potential impact

    Prioritizing based on risk assessment and potential impact is the correct approach because effective risk management & mitigation in the apha pharmacy-based immunization certificate field requires adherence to professional standards, evidence-based practices, and systematic methodology. This approach ensures consistent, high-quality outcomes while maintaining professional accountability.

  2. A apha pharmacy-based immunization certificate professional discovers a discrepancy during quality assurance & compliance review. What is the most appropriate immediate action?

    Answer: Engaging stakeholders collaboratively to align goals and expectations

    Engaging stakeholders collaboratively to align goals and expectations is the correct approach because effective quality assurance & compliance in the apha pharmacy-based immunization certificate field requires adherence to professional standards, evidence-based practices, and systematic methodology. This approach ensures consistent, high-quality outcomes while maintaining professional accountability.

  3. Why is obtaining informed consent important before vaccination?

    Answer: To ensure patients understand the procedure

    Informed consent ensures that the patient understands the benefits, risks, and any potential side effects before receiving a vaccine.

  4. Under NCVIA, which vaccines REQUIRE a current VIS to be given to the patient or guardian before administration?

    Answer: All vaccines covered by the National Vaccine Injury Compensation Program

    Federal law mandates VIS distribution for all vaccines covered by the National Vaccine Injury Compensation Program regardless of setting.

  5. What is the first step in evaluating a patient for vaccination?

    Answer: Review the patient’s medical history

    Screening the patient’s medical history helps identify contraindications and ensures safe vaccine administration.

  6. Latex-containing vial stoppers or syringe plungers present a risk for which patient population?

    Answer: Patients with documented latex hypersensitivity

    Latex-sensitive patients may experience allergic reactions from contact with latex-containing vaccine packaging components and require latex-free alternatives.

  7. Which action helps minimize pain during vaccine administration?

    Answer: Quick, steady injection

    Injecting the vaccine quickly and steadily, along with relaxing the muscle, can help minimize discomfort for the patient.

  8. According to federal requirements, when must a Vaccine Information Statement be provided to the patient or legal guardian?

    Answer: Before each dose of the vaccine is administered

    Federal law requires that a VIS be given to patients or their legal representatives before EACH dose of a covered vaccine is administered.

  9. Which of the following best explains why documentation of the vaccine administration site (e.g., left deltoid) is important?

    Answer: It aids in assessing adverse events such as SIRVA and ensures proper technique evaluation

    Documenting the injection site is clinically important for identifying adverse events like Shoulder Injury Related to Vaccine Administration (SIRVA), which is associated with improper deltoid administration.

  10. When completing a VAERS report after a serious adverse event, which information is considered essential to include?

    Answer: Manufacturer's lot number, vaccine administered, adverse event description, and patient demographics

    A complete VAERS report includes the vaccine name, lot number, patient demographics, adverse event details, and timing to help identify safety signals.

  11. What is the purpose of maintaining a vaccine temperature log, and how does it support risk management?

    Answer: It provides documentation to identify excursions early, prevent use of compromised vaccines, and support insurance claims

    Temperature logs detect excursions early so compromised vaccines can be discarded, preventing ineffective vaccination and supporting regulatory and insurance documentation.

  12. Which communication technique is MOST effective for assessing a patient's understanding of post-vaccination instructions?

    Answer: Using the teach-back method to have the patient repeat key instructions

    The teach-back method confirms comprehension by asking patients to restate information in their own words.

  13. At what interval should the Tdap booster be administered in adults?

    Answer: Every 10 years

    Adults should receive a Tdap booster every 10 years to maintain protection against tetanus, diphtheria, and pertussis.

  14. A physician contacts the pharmacy questioning why a shared patient received a vaccine without prior notification. The pharmacist should:

    Answer: Explain pharmacist prescriptive authority and offer to share immunization records going forward

    Collaborative relationships with prescribers are strengthened by professional communication and proactive record sharing rather than defensiveness.

  15. Which of the following vaccines requires pharmacists to follow special federal age restrictions under the 2023 PREP Act declaration?

    Answer: COVID-19 vaccines, which have had age-specific authorization requirements tied to emergency use or full approval status

    COVID-19 vaccine PREP Act declarations and EUA/approval conditions have included specific age thresholds that pharmacists must verify before administration.

  16. Who jointly manages the Vaccine Adverse Event Reporting System (VAERS)?

    Answer: The FDA and the CDC

    VAERS is co-managed by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).

  17. A pharmacist receives a gift from a vaccine manufacturer in exchange for preferentially recommending their product. This practice:

    Answer: Constitutes a conflict of interest that violates professional ethics

    Accepting gifts in exchange for preferential product recommendations creates a conflict of interest that compromises objectivity and violates professional ethics.

  18. Which of the following is an example of a pharmacist fulfilling the ethical duty of patient advocacy in immunization practice?

    Answer: Alerting a patient that their insurer denied coverage for a recommended vaccine and explaining assistance programs

    Patient advocacy means actively helping patients navigate barriers to care, including insurance denials, by connecting them with resources and assistance programs.

  19. When documenting a vaccine administered at the pharmacy, which piece of information is LEAST important for communication with the patient's provider?

    Answer: The pharmacist's personal opinion of the patient's vaccine literacy

    Documentation should include clinical facts; subjective opinions about vaccine literacy are not standard elements of immunization records.

  20. What is the purpose of the Vaccines for Children (VFC) program and how does it affect pharmacy immunization practice?

    Answer: VFC provides free vaccines to eligible children through enrolled providers, including pharmacies that meet program requirements

    The VFC program provides free vaccines to eligible children (Medicaid-enrolled, uninsured, underinsured, or American Indian/Alaska Native) through enrolled VFC providers, including qualifying pharmacies.